{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T04:07:50Z","timestamp":1746504470628,"version":"3.40.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,5]]},"DOI":"10.7759\/cureus.83533","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T20:49:12Z","timestamp":1746478152000},"source":"Crossref","is-referenced-by-count":0,"title":["Management of Mycotic Abdominal Aortic Aneurysm Caused by Levofloxacin- and Ampicillin-Resistant Campylobacter fetus With Synthetic Vascular Graft Replacement Surgery and Long-Term Minocycline Therapy"],"prefix":"10.7759","author":[{"given":"Jun","family":"Makino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fukumi U","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01447-23","article-title":"Antimicrobial susceptibilities of Campylobacter fetus: report from a reference laboratory","volume":"62","author":"Zhang MM","year":"2024","unstructured":"Zhang MM, Melton TA, Akhtar H, Shah A, Schuetz AN, Clement J, Stevens RW. Antimicrobial susceptibilities of Campylobacter fetus: report from a reference laboratory. J Clin Microbiol. 2024, 62:e0144723. 10.1128\/jcm.01447-23","journal-title":"J Clin Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu085","article-title":"Campylobacter fetus infections in humans: exposure and disease","volume":"58","author":"Wagenaar JA","year":"2014","unstructured":"Wagenaar JA, van Bergen MA, Blaser MJ, Tauxe RV, Newell DG, van Putten JP. Campylobacter fetus infections in humans: exposure and disease. Clin Infect Dis. 2014, 58:1579-86. 10.1093\/cid\/ciu085","journal-title":"Clin Infect Dis"},{"key":"ref3","unstructured":"CLSI publishes CLSI M100 - performance standards for antimicrobial susceptibility testing, 33rd edition. (2023). Accessed. April 10, 2025: https:\/\/clsi.org\/about\/press-releases\/clsi-publishes-m100-performance-standards-for-antimicrobial-susceptibility-test...."},{"key":"ref4","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 15.0. (2025). Accessed. May 1, 2025: https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_15.0_Breakpoint_Tables.pdf."},{"key":"ref5","unstructured":"BIOM\u00c9RIEUX. the value of MALDI-TOF technology in species-level identification. (2025). Accessed: April 10, 2025: https:\/\/www.biomerieux.com\/corp\/en\/education\/resource-hub\/scientific-library\/pharma-microorganisms-library\/mass-spect...."},{"key":"ref6","unstructured":"BIOM\u00c9RIUX. VITEK\u00ae 2: microbiology with confidence. (2025). Accessed: April 10, 2025: https:\/\/www.biomerieux-usa.com\/sites\/subsidiary_us\/files\/18-vitek2 systembrochure_v2.pdf."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1538-7","article-title":"Clinical and epidemiological analysis of Campylobacter fetus subsp. fetus infections in humans and comparative genetic analysis with strains isolated from cattle","volume":"16","author":"Escher R","year":"2016","unstructured":"Escher R, Brunner C, von Steiger N, Brodard I, Droz S, Abril C, Kuhnert P. Clinical and epidemiological analysis of Campylobacter fetus subsp. fetus infections in humans and comparative genetic analysis with strains isolated from cattle. BMC Infect Dis. 2016, 16:198. 10.1186\/s12879-016-1538-7","journal-title":"BMC Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1128\/jb.175.16.4979-4984.1993","article-title":"Shift in S-layer protein expression responsible for antigenic variation in Campylobacter fetus","volume":"175","author":"Wang E","year":"1993","unstructured":"Wang E, Garcia MM, Blake MS, Pei Z, Blaser MJ. Shift in S-layer protein expression responsible for antigenic variation in Campylobacter fetus. J Bacteriol. 1993, 175:4979-84. 10.1128\/jb.175.16.4979-4984.1993","journal-title":"J Bacteriol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2023.12.008","article-title":"Infective native aortic aneurysm: a Delphi consensus document on treatment, follow up, and definition of cure","volume":"67","author":"Wyss TR","year":"2024","unstructured":"Wyss TR, Giardini M, S\u00f6relius K. Infective native aortic aneurysm: a Delphi consensus document on treatment, follow up, and definition of cure. Eur J Vasc Endovasc Surg. 2024, 67:654-61. 10.1016\/j.ejvs.2023.12.008","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"ref10","unstructured":"Campylobacter infections medication. (2024). Accessed. May 1, 2025: https:\/\/emedicine.medscape.com\/article\/213720-medication?form=fpf."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000457","article-title":"Vascular graft infections, mycotic aneurysms, and endovascular infections: a scientific statement from the American Heart Association","volume":"134","author":"Wilson WR","year":"2016","unstructured":"Wilson WR, Bower TC, Creager MA, et al.. Vascular graft infections, mycotic aneurysms, and endovascular infections: a scientific statement from the American Heart Association. Circulation. 2016, 134:e412-60. 10.1161\/CIR.0000000000000457","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2023.11.002","article-title":"Editor\u2019s choice - European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms","volume":"67","author":"Wanhainen A","year":"2024","unstructured":"Wanhainen A, Van Herzeele I, Bastos Goncalves F, et al.. Editor\u2019s choice - European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms. Eur J Vasc Endovasc Surg. 2024, 67:192-331. 10.1016\/j.ejvs.2023.11.002","journal-title":"Eur J Vasc Endovasc Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/361396-management-of-mycotic-abdominal-aortic-aneurysm-caused-by-levofloxacin--and-ampicillin-resistant-campylobacter-fetus-with-synthetic-vascular-graft-replacement-surgery-and-long-term-minocycline-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T20:49:13Z","timestamp":1746478153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/361396-management-of-mycotic-abdominal-aortic-aneurysm-caused-by-levofloxacin--and-ampicillin-resistant-campylobacter-fetus-with-synthetic-vascular-graft-replacement-surgery-and-long-term-minocycline-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.83533","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,5]]}}}